NUZ neurizon therapeutics limited

Amylyx class action Relyvrio, page-3

  1. 486 Posts.
    lightbulb Created with Sketch. 780
    Hi All,

    Brilliant post KPAX c/o Quiltman.

    When shareholders, current and prospective, grasp the magnitude of the latest results of the MEND trial, the selling will stop.

    That being said, as our new CEO stated, "BLOCKBUSTER", there is a reason for that.

    Put simply, MPL is a blockbuster drug!!

    Hold onto your shares, as when ODD, is approved, BP's, will want to partner up.

    That's when things will get interesting!

    FOMO, is just about to set in, again!!

    As Always

    Best

    Mickey Mouse
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
0.000(0.00%)
Mkt cap ! $76.30M
Open High Low Value Volume
15.5¢ 15.5¢ 15.5¢ $13.20K 85.20K

Buyers (Bids)

No. Vol. Price($)
6 46809 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 25800 2
View Market Depth
Last trade - 15.53pm 22/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.